Role of protein disulfide isomerase and other thiol-reactive proteins in HIV-1 envelope protein-mediated fusion

被引:85
|
作者
Ou, Wu [1 ]
Silver, Jonathan [1 ]
机构
[1] NIAID, Lab Mol Microbiol, NIH, Bethesda, MD 20892 USA
关键词
HIV-1; fusion; protein disulfide isomerase; thioredoxin siRNA;
D O I
10.1016/j.virol.2006.01.041
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Cell-surface protein disulfide isomerase (PDI) has been proposed to promote disulfide bond rearrangements in HIV-1 envelope protein (Env) that accompany Env-mediated fusion. We evaluated the role of PDI in ways that have not been previously tested by downregulating PDI with siRNA and by overexpressing wild-type or variant forms of PDI in transiently and stably transfected cells. These manipulations, as well as treatment with anti-PDI antibodies, had only small effects on infection or cell fusion mediated by NL4-3 or AD8 strains of HIV-1. However, the cell-surface thiol-reactive reagent 5, 5 '-dithiobis(2-nitrobenzoic acid) (DTNB) had a much stronger inhibitory effect in our system, suggesting that cell-surface thiol-containing molecules other than PDI, acting alone or in concert, have a greater effect than PDI on HIV-1 Env-mediated fusion. We evaluated one such candidate, thioredoxin, a PDI family member reported to reduce a labile disulfide bond in CD4. We found that the ability of thioredoxin to reduce the disulfide bond in CD4 is enhanced in the presence of HIV-1 Env gp120 and that thioredoxin also reduces disulfide bonds in gp120 directly in the absence of CD4. We discuss the implications of these observations for identification of molecules involved in disulfide rearrangements in Env during fusion. Published by Elsevier Inc.
引用
收藏
页码:406 / 417
页数:12
相关论文
共 50 条
  • [21] Stoichiometry of murine leukemia virus envelope protein-mediated fusion and its neutralization
    Ou, Wu
    Silver, Jonathan
    JOURNAL OF VIROLOGY, 2006, 80 (24) : 11982 - 11990
  • [22] Molecular makeup of HIV-1 envelope protein
    Veljkovic, V
    Veljkovic, N
    Metlas, R
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2004, 23 (5-6) : 383 - 411
  • [23] A DISSECTION OF STEPS LEADING TO VIRAL ENVELOPE PROTEIN-MEDIATED MEMBRANE-FUSION
    BLUMENTHAL, R
    SCHOCH, C
    PURI, A
    CLAGUE, MJ
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES-SERIES, 1991, 635 : 285 - 296
  • [24] Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is required for fusion
    Barbouche, R
    Miquelis, R
    Jones, IM
    Fenouillet, E
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (05) : 3131 - 3136
  • [25] HIV-1 gp41-targeting fusion inhibitory peptides enhance the gp120-targeting protein-mediated inactivation of HIV-1 virions
    Qi, Qianqian
    Wang, Qian
    Chen, Weizao
    Du, Lanying
    Dimitrov, Dimiter S.
    Lu, Lu
    Jiang, Shibo
    EMERGING MICROBES & INFECTIONS, 2017, 6 : 1 - 7
  • [26] REDUCTION OF DISULFIDE BONDS IN RECOMBINANT HIV ENVELOPE GLYCOPROTEIN GP120 BY PROTEIN DISULFIDE-ISOMERASE
    GALLINA, A
    MANDEL, R
    RYSER, HJP
    MOLECULAR BIOLOGY OF THE CELL, 1995, 6 : 1044 - 1044
  • [27] Biochemistry and Biophysics of HIV-1 gp41-Membrane Interactions and Implications for HIV-1 Envelope Protein Mediated Viral-Cell Fusion and Fusion Inhibitor Design
    Cai, Lifeng
    Gochin, Miriam
    Liu, Keliang
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2011, 11 (24) : 2959 - 2984
  • [28] A Small-Molecule Inhibitor of Nipah Virus Envelope Protein-Mediated Membrane Fusion
    Niedermeier, Sabine
    Singethan, Katrin
    Rohrer, Sebastian G.
    Matz, Magnus
    Kossner, Markus
    Diederich, Sandra
    Maisner, Andrea
    Schmitz, Jens
    Hiltensperger, Georg
    Baumann, Knut
    Holzgrabe, Ulrike
    Schneider-Schaulies, Jurgen
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (14) : 4257 - 4265
  • [29] Thiol/disulfide exchange is a prerequisite for CXCR4-tropic HIV-1 envelope-mediated T-cell fusion during viral entry
    Markovic, I
    Stantchev, TS
    Fields, KH
    Tiffany, LJ
    Tomiç, M
    Weiss, CD
    Broder, CC
    Strebel, K
    Clouse, KA
    BLOOD, 2004, 103 (05) : 1586 - 1594
  • [30] GLYCOSYLATION OF HIV-1 ENVELOPE PROTEIN - VACCINE CONSIDERATION
    LEE, TH
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (06): : 679 - 679